A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting it exclusive rights to leverage its antibody ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Charles River Laboratories International, Inc. , ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has announced updates to its comprehensive portfolio of ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy ...

Discovery Reveals Protein Involved in ... The scientists showed ... NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma Apr. 4, 2025 — A novel cell ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical app ...

Of late I have been working with CAR NK cells so I decided to record a monologue series on NK cell discovery milestones. Check out the first part here! Monolog 21 - Discovery of NK cells (Part-1 ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

Northeastern University scientists have discovered that a protein in the human brain could potentially be used to grow new ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Researchers at Umeå University, Sweden, have discovered a previously unknown type of connective tissue cells that surround ...